Skip to main content
Top
Published in: Obesity Surgery 3/2015

01-03-2015 | Original Contributions

Downgrading of Type 2 Diabetes Mellitus (T2DM) after Obesity Surgery: Duration and Severity Matter

Authors: Mira Runkel, Silke Müller, Rayner Brydniak, Norbert Runkel

Published in: Obesity Surgery | Issue 3/2015

Login to get access

Abstract

Background

There is overwhelming evidence for the antidiabetic effect of obesity surgery, but few reports involve objective longitudinal measurements of severity of type-2 diabetes mellitus (T2DM). This study applies a grading scheme and analyses the prognostic impact of routine clinical factors.

Material and Methods

This retrospective study includes 77 obese diabetic patients with a preoperative BMI of 48.9 ± 7.8 kg/m2 who underwent gastric banding (n = 4), Roux-en-Y gastric bypass (n = 57), or sleeve gastrectomy (n = 16) between 2007 and 2013. A 6-point scoring system graded the level of antidiabetic therapy. Downgrading was calculated from the difference between pre- and postoperative grades.

Results

Downgrading reached its maximum at 3 months well before maximal weight loss: one grade in 6 (8 %) patients, two grades in 36 (47 %) patients, and three or more grades in 20 (26 %) patients. Age, gender, and preoperative weight had no impact on downgrading. There were no significant differences between gastric banding (median 1; 0–2), gastric bypass (median 2; 0–5), and sleeve gastrectomy (median 2; 0–4). Preoperative duration of T2DM and its severity grade were independent prognostic factors in multivariate analysis. The rate of patients who could discontinue insulin was more than 80 % when the duration of preexisting T2DM was less than 5 years as compared to 62 % when the duration was more than 5 years.

Conclusion

The severity of T2DM downgrades in most patients within the initial period of postoperative weight loss. Downgrading increases with shorter duration and lower severity grade of pre-existing T2DM.
Literature
1.
go back to reference Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50. Discussion 350–2 PMID: 7677463.CrossRefPubMedCentralPubMed Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222(3):339–50. Discussion 350–2 PMID: 7677463.CrossRefPubMedCentralPubMed
2.
go back to reference Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: Systematic review and meta-analysis. Am J Med. 2009;122(3):248–56. e5. PMID: 19272486.CrossRefPubMed Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: Systematic review and meta-analysis. Am J Med. 2009;122(3):248–56. e5. PMID: 19272486.CrossRefPubMed
3.
go back to reference Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with BMI <35 kg/m2. Diabetes Obes Metab. 2012;14(3):262–70. PMID: 22051116.CrossRefPubMed Li Q, Chen L, Yang Z, et al. Metabolic effects of bariatric surgery in type 2 diabetic patients with BMI <35 kg/m2. Diabetes Obes Metab. 2012;14(3):262–70. PMID: 22051116.CrossRefPubMed
4.
go back to reference Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. BMJ. 2013;347:f5934. PMID: 24149519.CrossRefPubMedCentralPubMed Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. BMJ. 2013;347:f5934. PMID: 24149519.CrossRefPubMedCentralPubMed
5.
go back to reference Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85. PMID: 22449317.CrossRefPubMed Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366(17):1577–85. PMID: 22449317.CrossRefPubMed
6.
go back to reference Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23. PMID: 18212316.CrossRefPubMed Dixon JB, O’Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316–23. PMID: 18212316.CrossRefPubMed
7.
go back to reference Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8. PMID: 21339423.CrossRefPubMed Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146(2):143–8. PMID: 21339423.CrossRefPubMed
8.
go back to reference Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76. PMID: 22449319.CrossRefPubMedCentralPubMed Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76. PMID: 22449319.CrossRefPubMedCentralPubMed
9.
go back to reference Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84. PMID: 14530719.PubMedCentralPubMed Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en-Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238(4):467–84. PMID: 14530719.PubMedCentralPubMed
10.
go back to reference Jurowich C, Thalheimer A, Hartmann D, et al. Improvement of type 2 diabetes mellitus (T2DM) after bariatric surgery—who fails in the early postoperative course? Obes Surg. 2012;22(10):1521–26. PMID: 22588846.CrossRefPubMed Jurowich C, Thalheimer A, Hartmann D, et al. Improvement of type 2 diabetes mellitus (T2DM) after bariatric surgery—who fails in the early postoperative course? Obes Surg. 2012;22(10):1521–26. PMID: 22588846.CrossRefPubMed
11.
go back to reference Hall TC, Pellen MG, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010;20(9):1245–50. PMID: 20524158.CrossRefPubMed Hall TC, Pellen MG, Sedman PC, et al. Preoperative factors predicting remission of type 2 diabetes mellitus after Roux-en-Y gastric bypass surgery for obesity. Obes Surg. 2010;20(9):1245–50. PMID: 20524158.CrossRefPubMed
12.
go back to reference Blackstone R, Bunt JC, Cortes MC, et al. Type 2 diabetes after gastric bypass: Remission in five models using HbA1c, fasting blood glucose, and medication status. Surg Obes Relat Dis. 2012;8(5):548–55. PMID: 22721581.CrossRefPubMed Blackstone R, Bunt JC, Cortes MC, et al. Type 2 diabetes after gastric bypass: Remission in five models using HbA1c, fasting blood glucose, and medication status. Surg Obes Relat Dis. 2012;8(5):548–55. PMID: 22721581.CrossRefPubMed
13.
go back to reference Rosenstock J, Banarer S, Fonseca VA, et al. The 11-β-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care. 2010;33(7):1516–22. PMID: 20413513.CrossRefPubMedCentralPubMed Rosenstock J, Banarer S, Fonseca VA, et al. The 11-β-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy. Diabetes Care. 2010;33(7):1516–22. PMID: 20413513.CrossRefPubMedCentralPubMed
15.
go back to reference Rubino F. Is type 2 diabetes an operable intestinal disease? a provocative yet reasonable hypothesis. Diabetes Care. 2008;31 Suppl 2:290–6. PMID: 18227499.CrossRef Rubino F. Is type 2 diabetes an operable intestinal disease? a provocative yet reasonable hypothesis. Diabetes Care. 2008;31 Suppl 2:290–6. PMID: 18227499.CrossRef
16.
go back to reference Fischer JE. The implications for the surgical community of bariatric surgery as a “cure” for type 2 diabetes. Am J Surg. 2013;206(1):136–41. PMID: 23790217.CrossRefPubMed Fischer JE. The implications for the surgical community of bariatric surgery as a “cure” for type 2 diabetes. Am J Surg. 2013;206(1):136–41. PMID: 23790217.CrossRefPubMed
17.
go back to reference Pinkney JH, Johnson AB, Gale EA. The big fat bariatric bandwagon. Diabetologia. 2010;53(9):1815–22. PMID: 20623218.CrossRefPubMed Pinkney JH, Johnson AB, Gale EA. The big fat bariatric bandwagon. Diabetologia. 2010;53(9):1815–22. PMID: 20623218.CrossRefPubMed
18.
go back to reference Ali MR, Maguire MB, Wolfe BM. Assessment of obesity-related comorbidities: a novel scheme for evaluating bariatric surgical patients. J Am Coll Surg. 2006;202(1):70–7. PMID: 16377499.CrossRefPubMed Ali MR, Maguire MB, Wolfe BM. Assessment of obesity-related comorbidities: a novel scheme for evaluating bariatric surgical patients. J Am Coll Surg. 2006;202(1):70–7. PMID: 16377499.CrossRefPubMed
19.
go back to reference DeMaria E, Winegar E, Pate V, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the bariatric outcomes longitudinal database. Ann Surg. 2010;252(3):559–67. PMID: 20739857.PubMed DeMaria E, Winegar E, Pate V, et al. Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the bariatric outcomes longitudinal database. Ann Surg. 2010;252(3):559–67. PMID: 20739857.PubMed
22.
go back to reference DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6(3):249–53. PMID: 20510288.CrossRefPubMed DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6(3):249–53. PMID: 20510288.CrossRefPubMed
23.
go back to reference Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass induced weight loss. Ann Surg. 2003;237(6):751–8. PMID: 12796570.PubMedCentralPubMed Sugerman HJ, Wolfe LG, Sica DA, et al. Diabetes and hypertension in severe obesity and effects of gastric bypass induced weight loss. Ann Surg. 2003;237(6):751–8. PMID: 12796570.PubMedCentralPubMed
24.
go back to reference Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8. PMID: 22723580.CrossRefPubMedCentralPubMed Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care. 2012;35(7):1420–8. PMID: 22723580.CrossRefPubMedCentralPubMed
25.
go back to reference Shimizu H, Timratana P, Schauer PR, et al. Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI<35 kg/m2. J Obes. 2012; 2012:9 pages. Article ID 147256. PMID: 22720136. Shimizu H, Timratana P, Schauer PR, et al. Review of Metabolic Surgery for Type 2 Diabetes in Patients with a BMI<35 kg/m2. J Obes. 2012; 2012:9 pages. Article ID 147256. PMID: 22720136.
26.
go back to reference Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: Comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg. 2008;12(5):945–52. PMID: 17940829.CrossRefPubMed Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: Comparison of BMI >35 and <35 kg/m2. J Gastrointest Surg. 2008;12(5):945–52. PMID: 17940829.CrossRefPubMed
27.
go back to reference Manger T, Stroh C. Surgery in morbid obesity: Quality assurance- state of the art and prospects. Obes Facts. 2011;4 Suppl 1:29–33. PMID: 22027287.CrossRefPubMed Manger T, Stroh C. Surgery in morbid obesity: Quality assurance- state of the art and prospects. Obes Facts. 2011;4 Suppl 1:29–33. PMID: 22027287.CrossRefPubMed
28.
go back to reference Gill RS, Sharma AM, Gill SS, et al. The impact of obesity on diabetes mellitus and the role of bariatric surgery. Maturitas. 2011;69(2):137–40. PMID: 21493021.CrossRefPubMed Gill RS, Sharma AM, Gill SS, et al. The impact of obesity on diabetes mellitus and the role of bariatric surgery. Maturitas. 2011;69(2):137–40. PMID: 21493021.CrossRefPubMed
29.
go back to reference Schernthaner G, Brix JM, Kopp HP, et al. Cure of type 2 diabetes by metabolic surgery? a critical analysis of the evidence in 2010. Diabetes Care. 2011;34(2):355–60. PMID: 21525482.CrossRef Schernthaner G, Brix JM, Kopp HP, et al. Cure of type 2 diabetes by metabolic surgery? a critical analysis of the evidence in 2010. Diabetes Care. 2011;34(2):355–60. PMID: 21525482.CrossRef
30.
31.
go back to reference Shah SS, Todkar JS, Shah PS, et al. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2). Surg Obes Relat Dis. 2010;6(4):332–8. PMID: 19733515.CrossRefPubMedCentralPubMed Shah SS, Todkar JS, Shah PS, et al. Diabetes remission and reduced cardiovascular risk after gastric bypass in Asian Indians with body mass index <35 kg/m(2). Surg Obes Relat Dis. 2010;6(4):332–8. PMID: 19733515.CrossRefPubMedCentralPubMed
32.
go back to reference Parikh M, Ayoung-Chee P, Romanos E, et al. Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass and biliopancreatic diversion. J Am Coll Surg. 2007;205(5):631–5. PMID: 17964437.CrossRefPubMed Parikh M, Ayoung-Chee P, Romanos E, et al. Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass and biliopancreatic diversion. J Am Coll Surg. 2007;205(5):631–5. PMID: 17964437.CrossRefPubMed
33.
go back to reference Hutter MM, Schirmer BD, Jones DB, et al. First report from the American college of surgeons bariatric surgery center network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254(3):410–22. PMID: 21865942.CrossRefPubMedCentralPubMed Hutter MM, Schirmer BD, Jones DB, et al. First report from the American college of surgeons bariatric surgery center network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254(3):410–22. PMID: 21865942.CrossRefPubMedCentralPubMed
34.
go back to reference Pories WJ, The IDF. Statement: a big and long-awaited step for our diabetic patients. Obes Surg. 2011;21(10):1487–9. PMID: 21847715.CrossRefPubMed Pories WJ, The IDF. Statement: a big and long-awaited step for our diabetic patients. Obes Surg. 2011;21(10):1487–9. PMID: 21847715.CrossRefPubMed
35.
go back to reference Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6(3):254–9. PMID: 20303324.CrossRefPubMed Chikunguwo SM, Wolfe LG, Dodson P, et al. Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2010;6(3):254–9. PMID: 20303324.CrossRefPubMed
36.
go back to reference Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232(4):515–29. PMID: 10998650.CrossRefPubMedCentralPubMed Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232(4):515–29. PMID: 10998650.CrossRefPubMedCentralPubMed
Metadata
Title
Downgrading of Type 2 Diabetes Mellitus (T2DM) after Obesity Surgery: Duration and Severity Matter
Authors
Mira Runkel
Silke Müller
Rayner Brydniak
Norbert Runkel
Publication date
01-03-2015
Publisher
Springer US
Published in
Obesity Surgery / Issue 3/2015
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-014-1419-3

Other articles of this Issue 3/2015

Obesity Surgery 3/2015 Go to the issue